SCHEMBL4149223

SCHEMBL4149223

CCC(CC)(CCCCCCCC(N)=O)C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 2/20 0.42
FAAH O00519 2/20 0.42
MEN1 O00255 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM4E B2RXH2 2/20 0.39
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
SMPD1 P17405 2/20 0.34
FDPS P14324 1/20 0.34
CES2 O00748 4/20 0.33
CES1 P23141 4/20 0.33
SCN5A Q14524 3/20 0.33
SCN9A Q15858 3/20 0.33
ABHD16A O95870 1/20 0.33
CNR1 P21554 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8496388 1.00 SOAT1 (0.42) SOAT1FAAHMEN1TP53CYP1A2
SCHEMBL989014 1.00 SOAT1 (0.42) SOAT1FAAHMEN1TP53CYP1A2
Hydrochloric Acid SCHEMBL2418570 0.98 SOAT1 (0.41) SOAT1FAAHMEN1TP53CYP1A2
Hydrochloric Acid SCHEMBL2413365 0.98 SOAT1 (0.41) SOAT1FAAHMEN1TP53CYP1A2
SCHEMBL7079388 0.98 CYP4F2 (0.40) SOAT1FAAHMEN1TP53CYP1A2
SCHEMBL4147412 0.91 CYP4F2 (0.37) SOAT1FAAHMEN1TP53CYP1A2
SCHEMBL8496383 0.86 MEN1 (0.41) SOAT1FAAHMEN1TP53CYP1A2
SCHEMBL3903689 0.86 SOAT1 (0.55) SOAT1FAAHMEN1TP53CYP1A2
SCHEMBL11782562 0.86 SOAT1 (0.55) SOAT1FAAHMEN1TP53CYP1A2
SCHEMBL7521923 0.86 SOAT1 (0.55) SOAT1FAAHMEN1TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090131657-A1 PROCESS FOR ALKENYLATING CARBOXAMIDES BASF SE (DE) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131657-A1 PROCESS FOR ALKENYLATING CARBOXAMIDES PRMT5, CYC1, CBR3 SOAT1 3570/4885FAAH 501/4885MEN1 303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.